Fei Chen | Synthetic Biology | Cost-effectiveness Award

Fei Chen | Synthetic Biology | Cost-effectiveness Award

Dr. Fei Chen, Beijing Institute of Genomics, China.

Publication profile

Scopus
Googlescholar

Education

    • Ph.D. in Biology (Institution: CAS) ๐ŸŽ“
    • Postdoctoral Researcher in Genomics ๐Ÿ”ฌ

Experience

    • Professor (PI) at Beijing Institute of Genomics, CAS ๐Ÿซ
    • Chief Scientist, National Key R&D Program ๐Ÿง‘โ€๐Ÿ”ฌ
    • Editorial Board Member of multiple international journals ๐Ÿ“š
    • Principal Investigator for over 30 funded research projects ๐Ÿ’ผ

Suitability For The Award

Dr. Fei Chen is an outstanding candidate for the Cost-Effectiveness Award due to his ability to maximize scientific impact and innovation while efficiently utilizing resources. His exemplary track record of high-impact research in genomics, biosecurity, and synthetic biology demonstrates strategic allocation of funding and significant contributions to addressing critical global health challenges. Dr. Chenโ€™s leadership in research projects, prolific publication record, and innovative patents showcase his commitment to advancing science with optimal resource management.

Professional Development 

Awards and Honors

  • Chinese Medical Science and Technology Award ๐Ÿ†
  • Huaxia Medical Science and Technology Award ๐Ÿ…
  • CAS โ€œHundred Talents Programโ€ (Category A) Recruitment ๐ŸŽ–๏ธ
  • National Key R&D Program Chief Scientist ๐Ÿ‘จโ€๐Ÿ”ฌ
  • Over 20 authorized patents, including 4 PCT patents ๐Ÿ“œ

Publications

  • Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2024 โ€“ Nucleic Acids Research, 2024, 52(1 D), cited by 50 ๐Ÿ“š๐Ÿงฌ
  • HervD Atlas: A curated knowledgebase of associations between human endogenous retroviruses and diseases โ€“ Nucleic Acids Research, 2024, 52(D1), cited by 5 ๐Ÿ”ฌ๐Ÿงช
  • Spatiotemporal single-cell transcriptomic profiling reveals inflammatory cell states in a mouse model of diffuse alveolar damage โ€“ Exploration, 2023, 3(3), cited by 11 ๐Ÿ๐Ÿ”
  • Comparative transcriptome analysis of SARS-CoV-2, SARS-CoV, MERS-CoV, and HCoV-229E identifying potential IFN/ISGs targets for inhibiting virus replication โ€“ Frontiers in Medicine, 2023, 10, cited by 0 ๐Ÿฆ ๐Ÿง‘โ€โš•๏ธ
  • Genomic epidemiology and heterogeneity of Providencia and their bla NDM-1-carrying plasmids โ€“ Emerging Microbes and Infections, 2023, 12(2), cited by 4 ๐Ÿงฌ๐Ÿฆ 
  • Proteomic analyses of smear-positive/negative tuberculosis patients uncover differential antigen-presenting cell activation and lipid metabolism โ€“ Frontiers in Cellular and Infection Microbiology, 2023, 13, cited by 0 ๐Ÿฉบ๐Ÿ’Š
  • Comparative genomic analysis reveals differential genomic characteristics and featured genes between rapid- and slow-growing non-tuberculous mycobacteria โ€“ Frontiers in Microbiology, 2023, 14, cited by 0 ๐Ÿงซ๐Ÿ”ฌ